iRGD Peptide cyclo-CRGDKGPDC, CAS 1392278-76-0

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

US$177.67

Excluding tax and shipping fees

In stock

Description

About iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

iRGD Peptide (CRGDKGPDC), CAS 1392278-76-0 is a Tumour-penetrating peptide used in nano drug delivery for cancer-targeting research. The iRGD Peptide (CRGDKGPDC), CAS 1392278-76-0 Peptide, H-CRGDKGPDC-OH (cyclic peptide Cys-Cys) from JPT is produced under strict quality control and quality management.

iRGD Peptide (CRGDKGPDC), CAS 1392278-76-0- Specifications

Peptide sequence: H-CRGDKGPDC-OH (cyclic peptide Cys-Cys)

Amount: 1 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

iRGD Peptide - cyclo-CRGDKGPDC - CAS 1392278-76-0.pdf

Properties

Properties of iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

1 mg

Cancer peptides

Cancer

Freeze-dried in plastic vial

Artificial

Other

>90% (HPLC-MS)

Further Information to iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

Values

H-CRGDKGPDC-OH (cyclic peptide, Cys-Cys)

cyclized RGD cancer peptide